-

Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company

CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the acquisition of Koha Health, a full-service revenue cycle management (RCM) company. With this acquisition, Veradigm further adds to its depth of offerings and expertise as a leading provider of revenue cycle services in the ambulatory healthcare market.

“Today’s announcement represents an exciting opportunity for Veradigm to scale our revenue cycle services portfolio by leveraging additional capabilities and subject matter expertise to better serve the needs of the market,” said Tom Langan, President, and Chief Commercial Officer at Veradigm.

This acquisition brings additional Musculoskeletal Medicine (MSK) specialty subject matter expertise to the Veradigm Network along with an enhanced ability to deliver revenue cycle services to ambulatory healthcare provider practices and ambulatory surgical centers (ASCs) utilizing various electronic health record (EHR) systems. Veradigm is strengthening its end-to-end revenue cycle services portfolio to help bring added value to clients and unlock additional market opportunities.

“Key synergies exist, including expanded growth opportunities, enabling cost savings and improved service delivery all while continuing to focus on client satisfaction,” said Brian Hall, President, and Chief Executive Officer at Koha Health. “We are excited to join the Veradigm Network and leverage the additional tools and resources needed to help our clients achieve financial success and deliver a better patient experience.”

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

© 2023 Veradigm Inc. and/or its affiliates. All rights reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

Veradigm Inc.

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

More News From Veradigm Inc.

Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX) (“Veradigm” or the “Company”), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the “Board”) appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of th...

Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, provided updates on financial information for fiscal 2023 and 2024 and an outlook for fiscal 2025. “We remain confident in Veradigm's business model and our value proposition,” said Tom Langan, Interim Chief Executive Officer. “We believe our core business is sound. We remain focused on remediating our material weaknesses and other internal control deficiencies, becoming current...

Veradigm Files Fiscal 2022 Form 10-K and Restated Financial Statements

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that it filed its comprehensive Annual Report on Form 10-K for the year ended December 31, 2022, which also contains certain restated financial statements for periods in fiscal year 2022, 2021 and 2020 (the “2022 Form 10-K”), with the Securities and Exchange Commission (“SEC”). “This filing represents an important step toward regaining compliance with our financia...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.